Log in to search using one of your social media accounts:

 

FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of the pain reliever propoxyphene because new data show that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 3, 2017 Category: Drugs & Pharmacology Source Type: news

Darvon (Propoxyphene) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 29, 2016 Category: Drugs & Pharmacology Source Type: news

Darvon Compound (Propoxyphene, Aspirin, and Caffeine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 29, 2016 Category: Drugs & Pharmacology Source Type: news

On-Site Drug Testing Cups target hotel industry.
Used for pre-employment screening, FDA-approved QuikScreen Drug Testing Cups detect drugs such as Amphetamine, Cocaine, Opiates, Tri-cyclic Antidepressant, Propoxyphene, and Methamphetamine in urine samples within 5 minutes. CLIA-waived products do not require any handling or manipulation to activate test. Providing 18-24 month shelf life, each cup includes temperature strip and identification label. Leak-proof design enables positive specimens to be shipped to laboratory for GC/MS...This story is related to the following:Urinalysis Equipment |Specimen Cups (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 27, 2016 Category: Medical Equipment Source Type: news

FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of the pain reliever propoxyphene because new data show that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 25, 2016 Category: Drugs & Pharmacology Source Type: news

Opioid Overdoses Decrease After Abuse-Deterrent Painkillers Enter Market, Propoxyphene Exits
Curbing opioid overdoses in the United States has not only been the goal of many in the medical community, it has also been an initiative of President Barack Obama's. A couple of recent changes in the painkiller market, however, may have contributed to a significant decrease in both opioid dispensing and overdoses. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 27, 2015 Category: Pharmaceuticals Authors: CJ Arlotta Source Type: news

National Drop in Opioid Prescriptions, OverdoseNational Drop in Opioid Prescriptions, Overdose
After the introduction of abuse-deterrent formulations of oxycodone and the withdrawal of propoxyphene from the market, there has been a drop in opioid prescriptions and prescription opioid overdose. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 21, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news

propoxyphene and acetaminophen, Darvocet A500; Darvocet-N, Wygesic
Title: propoxyphene and acetaminophen, Darvocet A500; Darvocet-N, WygesicCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 7/15/2013 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - July 15, 2013 Category: Anesthesiology Source Type: news

propoxyphene and acetaminophen, Darvocet A500; Darvocet-N, Wygesic
Title: propoxyphene and acetaminophen, Darvocet A500; Darvocet-N, WygesicCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 7/15/2013 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 15, 2013 Category: Drugs & Pharmacology Source Type: news